RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of APVO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Aptevo Therapeutics Inc stock price on Thursday which ended trading at $4.69
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 11, 2024 Gain 6.59% PDF

The Aptevo Therapeutics Inc stock price gained 15.52% on the last trading day (Thursday, 28th Mar 2024), rising from $4.06 to $4.69. During the last trading day the stock fluctuated 26.53% from a day low at $3.95 to a day high of $5.00. The price has risen in 6 of the last 10 days but is still down by -6.94% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 260 thousand more shares were traded than the day before. In total, 289 thousand shares were bought and sold for approximately $1.36 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 215.62% during the next 3 months and, with a 90% probability hold a price between $5.18 and $25.04 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

APVO Signals & Forecast

The Aptevo Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.42 and $2.45. A breakdown below any of these levels will issue sell signals. Aptevo Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -28.94%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Aptevo Therapeutics Inc stock

Aptevo Therapeutics Inc finds support from accumulated volume at $4.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.05 between high and low, or 26.53%. For the last week, the stock has had daily average volatility of 12.62%.

Our recommended stop-loss: $4.40 (-6.10%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 15 days ago.)

Trading Expectations (APVO) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Aptevo Therapeutics Inc to open at $4.55, and during the day (based on 14 day Average True Range), to move between $4.00 and $5.38, which gives a possible trading interval of +/-$0.691 (+/-14.74%) up or down from last closing price. If Aptevo Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 29.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.48 (4.48%) than the resistance at $4.96 (5.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aptevo Therapeutics Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aptevo Therapeutics Inc stock to perform well in the short-term.

Current score: 3.899 Buy Candidate Unchanged

Predicted Opening Price for Aptevo Therapeutics Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$4.55 ( 3.07%) $4.69

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for APVO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.59 19.27 %
R2 5.19 10.74 %
R1 4.95 5.46 %
Current price: 4.69
Support S1 4.15 -11.61 %
S2 3.90 -16.88 %
S3 3.50 -25.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.42 15.57 %
R2 5.19 10.66 %
R1 4.96 5.76 %
Current price 4.69
Support S1 4.48 -4.48%
S2 4.40 -6.18%
S3 4.07 -13.22%

FAQ

What is the symbol for Aptevo Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Aptevo Therapeutics Inc is APVO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aptevo Therapeutics Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aptevo Therapeutics Inc stock to perform well in the short-term.

How to buy Aptevo Therapeutics Inc Stock?
Aptevo Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aptevo Therapeutics Inc Stock.

What's the current price of Aptevo Therapeutics Inc Stock?
As of the end of day on the 2024-03-28, the price of an Aptevo Therapeutics Inc (APVO) share was $4.69.

What is the 52-week high and low for Aptevo Therapeutics Inc Stock?
The 52-week high for Aptevo Therapeutics Inc Stock is $10.80 and the 52-week low is $0.125.

What is the market capitalization of Aptevo Therapeutics Inc Stock?
As of the 2024-03-28, the market capitalization of Aptevo Therapeutics Inc is 3.158M.

When is the next earnings date for Aptevo Therapeutics Inc?
The upcoming earnings date for Aptevo Therapeutics Inc is May 09, 2024.
Click to get the best stock tips daily for free!

About Aptevo Therapeutics Inc

Aptevo Therapeutics Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational ... APVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT